Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA | Journal of Experimental & Clinical Cancer Research | Full Text

Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA | Journal of Experimental & Clinical Cancer Research | Full Text

Featured review: Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA

Hepatocellular carcinoma (HCC) is a highly malignant disease with a poor prognosis and high mortality due to a low early diagnosis rate, resistance to systemic treatments and progression to late-stage liver disease. As a noninvasive detection method, liquid biopsy is expected to play an important role in the early diagnosis, dynamic monitoring of cancer patients and drug screening. In this review, Jie Li et al. focus on the clinical applications, recent studies and future prospects of liquid biopsy, particularly focusing on HCC.

Click here to access the full article. 

Click here to access all of the reviews published to date in Journal of Experimental & Clinical Cancer Research